These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 6362851

  • 1. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ, Kimball AP.
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [Abstract] [Full Text] [Related]

  • 2. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A, Pugh L, Israels LG, Johnston JB.
    Cancer Res; 1988 Jul 15; 48(14):3981-6. PubMed ID: 3260129
    [Abstract] [Full Text] [Related]

  • 3. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF, Fox RM.
    Br J Haematol; 1982 Apr 15; 50(4):627-36. PubMed ID: 6978147
    [Abstract] [Full Text] [Related]

  • 4. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG, Wohlhueter RM.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [Abstract] [Full Text] [Related]

  • 5. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul 15; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 6. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A, Glazer RI, Israels LG, Pugh L, Johnston JB.
    Cancer Res; 1987 May 01; 47(9):2498-503. PubMed ID: 3494509
    [Abstract] [Full Text] [Related]

  • 7. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB, Begleiter A, Pugh L, Leith MK, Wilkins JA, Cavers DJ, Israels LG.
    Cancer Res; 1986 Apr 01; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE, Selner M, Tan TH, Muhs WH, Robins MJ.
    Cancer Treat Rep; 1982 Feb 01; 66(2):317-26. PubMed ID: 6976834
    [Abstract] [Full Text] [Related]

  • 9. Treatment of multiple myeloma with deoxycoformycin.
    Belch AR, Henderson JF, Brox LW.
    Cancer Chemother Pharmacol; 1985 Feb 01; 14(1):49-52. PubMed ID: 3871175
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec 01; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 11. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
    Paine RM, Weston BJ, Clink HM, Kohn J, Neville AM, McGhee KG, Harrap KR.
    Cancer Treat Rep; 1981 Dec 01; 65(3-4):259-66. PubMed ID: 6972254
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS, Yu J, Yu AL.
    J Immunol; 1983 Dec 01; 131(6):2762-6. PubMed ID: 6196398
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR, Overgaard-Hansen K, Frederiksen S.
    Cancer Chemother Pharmacol; 1988 Dec 01; 21(1):35-9. PubMed ID: 3257721
    [Abstract] [Full Text] [Related]

  • 14. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM, Henderson JF.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1545-51. PubMed ID: 6980005
    [Abstract] [Full Text] [Related]

  • 15. Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycin.
    Russell NH, Prentice HG, Lee N, Piga A, Ganeshaguru K, Smyth JF, Hoffbrand AV.
    Br J Haematol; 1981 Sep 15; 49(1):1-9. PubMed ID: 6974003
    [Abstract] [Full Text] [Related]

  • 16. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH, Cory JG.
    Biochem Biophys Res Commun; 1998 Aug 28; 249(3):687-91. PubMed ID: 9731198
    [Abstract] [Full Text] [Related]

  • 17. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L, Ng A, Pollock E, Belch A.
    Cancer Res; 1984 Mar 28; 44(3):934-7. PubMed ID: 6607110
    [Abstract] [Full Text] [Related]

  • 18. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF, Mitchell BS, Koller CA, Coleman MS, Hutton JJ.
    Proc Natl Acad Sci U S A; 1980 Oct 28; 77(10):6157-61. PubMed ID: 6969403
    [Abstract] [Full Text] [Related]

  • 19. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS, Yu AL, Yu J.
    Cancer Invest; 1985 Oct 28; 3(3):225-33. PubMed ID: 3873981
    [Abstract] [Full Text] [Related]

  • 20. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W, Benjamin RS, Keating MJ, Freireich EJ.
    Cancer Res; 1982 May 28; 42(5):2092-6. PubMed ID: 6175407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.